BRIEF published on 06/08/2026 at 07:05, 20 days 2 hours ago ADOCIA presents promising results for BioChaperone® Lispro Positive Results Phase 3 Type 2 Diabetes BioChaperone Lispro Blood Glucose Control
BRIEF published on 06/08/2026 at 07:05, 20 days 2 hours ago Adocia's BioChaperone® Lispro: Promising Phase 3 Results Type 2 Diabetes Phase 3 Results ADOCIA BioChaperone® Lispro Glycemic Control
PRESS RELEASE published on 06/08/2026 at 07:00, 20 days 2 hours ago Inside Information / Other news releases Adocia announces positive Phase 3 results of BioChaperone® Lispro for type 2 diabetes, presenting superior glycemic control benefits over Humalog® Type 2 Diabetes Phase 3 Results ADOCIA BioChaperone® Lispro ADA 86th Scientific Session
BRIEF published on 04/21/2026 at 20:35, 2 months 6 days ago Adocia Reports 2025 Financial Results and Strategic Developments Corporate Governance Financial Results 2025 Biopharmaceutical Advancements BioChaperone® Technology Partnerships And Patents
PRESS RELEASE published on 04/21/2026 at 20:30, 2 months 6 days ago Inside Information / News release on accounts, results ADOCIA announces full year 2025 financial results, highlights positive Phase 3 results for diabetes treatment, and secures cash runway until Q2 2027. Company advancements in key technology platforms showcased Financial Results Diabetes Treatment Phase 3 Results ADOCIA Technology Platforms
BRIEF published on 04/21/2026 at 19:35, 2 months 6 days ago ADOCIA concludes a financial agreement with Vester Finance Treasury Funding Biopharmaceutical ADOCIA Vester Finance
BRIEF published on 04/21/2026 at 19:35, 2 months 6 days ago ADOCIA Secures €6 Million Shareholder Loan from Vester Finance Shareholder Loan Cash Runway ADOCIA BioChaperone® Vester Finance
PRESS RELEASE published on 04/21/2026 at 19:30, 2 months 6 days ago Inside Information / Other news releases Adocia secures €6.0 million shareholder loan from Vester Finance, extending cash runway until Q2 2027. Funds for BioChaperone and AdoXLong development Shareholder Loan ADOCIA Vester Finance Cash Runway Extension BioChaperone
BRIEF published on 12/08/2025 at 19:35, 6 months 19 days ago ADOCIA Announces Share and Voting Rights Update Voting Rights Shares Financial Disclosure Diabetes Treatment ADOCIA
PRESS RELEASE published on 12/08/2025 at 19:30, 6 months 19 days ago Inside Information / Other news releases Adocia SA releases total number of shares and voting rights as of December 8th, 2025. Company focuses on innovative therapeutic solutions for diabetes and obesity Voting Rights Shares Diabetes Obesity ADOCIA
Published on 06/27/2026 at 16:50, 16 hours 16 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 7 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 9 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 10 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 10 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 1 day 9 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 9 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 9 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 9 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 1 day 9 hours ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 07:00, 2 days 2 hours ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 07:30, 3 days 1 hour ago Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.
